Antonenko, S. and Telegeev, G. 2023. Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells. Experimental Oncology. 42, 2 (Jun. 2023), 109–114. DOI:https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-2.14533.